Dr. Jaffe's research interests include a long academic career investigating the use of biomarkers to characterize the pathobiology of acute cardiovascular disease. With investigators at Washington University in St. Louis, he helped develop and was responsible for the validation studies of the first cardiac troponin I assay. His cutting-edge research explores questions surrounding many commonly used cardiac biomarkers.
Dr. Jaffe is a highly esteemed national and international presenter who has co-authored five books and written more than 500 peer-reviewed articles, book chapters, and abstracts. His writings particularly focus on the use of both cardiac troponin and natriuretic peptides to characterize patients with both acute and chronic heart failure. Dr. Jaffe has received many awards and honors throughout his career, including the Citation of International Service from the American Heart Association. He is simply the ultimate authority on the use of many of these markers in the clinical arena and for that reason serves on many of the national and international groups who make guidelines in this area.
Dr. Jaffe completed his undergraduate studies at University of Maryland where he also earned his medical degree. He trained at Washington University School of Medicine in St. Louis, Missouri for house staff, Chief Residency and fellowship training and was on the faculty there for 22 years, rising to the rank of Professor of Medicine. He left in 1995 to become Chief to Cardiology and Associate Chair of Medicine for Academic Affairs at the State University of New York at Syracuse in 1995. In 1999, he was recruited to the Mayo Clinic in Cardiology and Laboratory Medicine.
As editor of eJIFCC I am glad that Professor Jaffe accepted to be the guest editor of this issue.
